Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CRCD vs BMNZ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CRCD Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

CRCD Overall Winner 6-Pillar Tally: CRCD 0 – 0 BMNZ (6 Tie) Matrix Metrics: CRCD 2 – 1 BMNZ

As of Nov 16, 2026, T-REX 2X Inverse CRCL Daily Target ETF (CRCD) is the stronger overall head-to-head candidate over BMNZ (BMNZ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CRCD carries a Unified Composite Score of 36.2/100 (SELL) at $3.80 (N/M Forward P/E, N/A operating margin), whereas BMNZ carries 31.8/100 (SELL) at $8.81 (N/M Forward P/E, N/A operating margin).

  • Defensive Composite Rating Caution: Although CRCD compares more favorably head-to-head, both CRCD (36.2/100 SELL) and BMNZ (31.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CRCD vs BMNZ
CRCD Cboe BZX Head-to-Head Winner
T-REX 2X Inverse CRCL Daily Target ETF
Institutional Equity
$3.80
+15.15% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -4.88β · 138% Vol
Unified Composite Score
36.2 / 100 SELL
Tech 15.0 Fund 31.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 72
RSI-14: 72.5 · SMA20: $2.51 · SMA50: $2.26
BMNZ US Equity
BMNZ
Institutional Equity
$8.81
+14.27% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -6.24β · 166% Vol
Unified Composite Score
31.8 / 100 SELL
Tech 50.0 Fund 29.0 Flow 50.0 Mom 36.5
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 66
RSI-14: 65.6 · SMA20: $6.37 · SMA50: $5.49

6-Pillar Scorecard Institutional Category Breakdown (CRCD 0 – 0 BMNZ)

Columns: Metric · CRCD · BMNZ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 222.7% (26th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CRCD (2) vs BMNZ (1)
Institutional Metric CRCD BMNZ Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
3% ($2–$73) 12% ($4–$48) Stronger Trend BMNZ
Beta / 30D Volatility
Risk Regime
-4.88β · 138% Vol -6.24β · 166% Vol Lower Realized Risk CRCD
Unified Institutional Score
Composite Signal
36.2 / 100 (SELL) 31.8 / 100 (SELL) Higher Composite CRCD
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CRCD +33.15 pp
CRCD: +79.25% · BMNZ: +46.1%
3M Horizon CRCD +18.42 pp
CRCD: -10.59% · BMNZ: -29.01%
6M Horizon CRCD +81.77 pp
CRCD: +28.38% · BMNZ: -53.39%
1Y Horizon BMNZ +27.65 pp
CRCD: -90.96% · BMNZ: -63.31%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRCD vs BMNZ. Trailing 12-month operating profitability (CRCD N/A vs BMNZ N/A) and valuation multiples (CRCD N/M vs BMNZ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

CRCD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
BMNZ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CRCD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 222.7%
IV Percentile 26th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CRCD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BMNZ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BMNZ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CRCD Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
BMNZ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CRCD vs BMNZ Key Questions & Quantitative Answers

As of Nov 16, 2026, T-REX 2X Inverse CRCL Daily Target ETF (CRCD) is the stronger overall head-to-head candidate over BMNZ (BMNZ) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). CRCD carries a Unified Composite Score of 36.2/100 (SELL) at $3.80 (N/M Forward P/E, N/A operating margin), whereas BMNZ carries 31.8/100 (SELL) at $8.81 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although CRCD compares more favorably head-to-head, both CRCD (36.2/100 SELL) and BMNZ (31.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

CRCD and BMNZ split Growth & Scale metrics: CRCD posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BMNZ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, CRCD generates N/A in USD-normalized revenue versus N/A for BMNZ. In operating R&D and SG&A reinvestment, CRCD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BMNZ.

CRCD and BMNZ trade at balanced relative valuation multiples. CRCD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BMNZ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CRCD (N/A ROE) versus BMNZ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, CRCD carries 222.7% implied volatility (26th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-4.88β · 138% Vol realized risk). By comparison, BMNZ carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-6.24β · 166% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.